We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-0.55%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$169B
AUM Growth
+$3.15B
Cap. Flow
+$5.8B
Cap. Flow %
3.43%
Top 10 Hldgs %
24.72%
Holding
6,611
New
423
Increased
2,034
Reduced
2,706
Closed
793

Sector Composition

Rank Sector Weight
1 Technology 11.19%
2 Financials 6.48%
3 Consumer Discretionary 5.4%
4 Healthcare 5.05%
5 Communication Services 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRS
4501
DELISTED
Verso Corporation
VRS
$64K ﹤0.01%
3,061
+1,351
+79% +$26.1K
ABUS icon
4502
Arbutus Biopharma
ABUS
$847M
$63K ﹤0.01%
14,679
+5,117
+54% +$17.1K
BFC icon
4503
Bank First Corp
BFC
$1.68B
$63K ﹤0.01%
890
+443
+99% +$30.9K
EOS
4504
Eaton Vance Enhance Equity Income Fund II
EOS
$1.12B
$63K ﹤0.01%
2,709
-13,276
-83% -$318K
IXUS icon
4505
iShares Core MSCI Total International Stock ETF
IXUS
$56.8B
$63K ﹤0.01%
884
-745
-46% -$54.3K
MBWM icon
4506
Mercantile Bank Corp
MBWM
$1.04B
$63K ﹤0.01%
1,981
+936
+90% +$29K
REVG
4507
DELISTED
REV Group
REVG
$63K ﹤0.01%
3,659
+1,775
+94% +$28.3K
ULCC icon
4508
Frontier Group Holdings
ULCC
$1.5B
$63K ﹤0.01%
3,961
+2,305
+139% +$35.6K
BCOV
4509
DELISTED
Brightcove, Inc.
BCOV
$63K ﹤0.01%
5,439
+2,583
+90% +$31.2K
CMAX
4510
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$63K ﹤0.01%
+217
New +$63.8K
CII icon
4511
BlackRock Enhanced Captial and Income Fund
CII
$964M
$62K ﹤0.01%
3,045
-4,282
-58% -$90.4K
DYN icon
4512
Dyne Therapeutics
DYN
$4.68B
$62K ﹤0.01%
3,791
+1,913
+102% +$33.9K
NUSC icon
4513
Nuveen ESG Small-Cap ETF
NUSC
$1.27B
$62K ﹤0.01%
1,428
+744
+109% +$32.8K
SILC icon
4514
Silicom
SILC
$201M
$62K ﹤0.01%
1,423
+129
+10% +$5.57K
TRC icon
4515
Tejon Ranch
TRC
$460M
$62K ﹤0.01%
3,491
-4,730
-58% -$84.1K
TSHA icon
4516
Taysha Gene Therapies
TSHA
$1.61B
$62K ﹤0.01%
3,321
+1,950
+142% +$37.1K
TZA icon
4517
Direxion Daily Small Cap Bear 3x ETF
TZA
$257M
$62K ﹤0.01%
200
XLRE icon
4518
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
$62K ﹤0.01%
1,390
-11,319
-89% -$526K
GATO
4519
DELISTED
Gatos Silver, Inc.
GATO
$62K ﹤0.01%
5,356
+3,668
+217% +$51.1K
APLT
4520
DELISTED
Applied Therapeutics
APLT
$61K ﹤0.01%
3,682
+585
+19% +$10.1K
ATOS icon
4521
Atossa Therapeutics
ATOS
$23M
$61K ﹤0.01%
1,247
+209
+20% +$12.2K
ESPR
4522
DELISTED
Esperion Therapeutics
ESPR
$61K ﹤0.01%
5,085
-148,288
-97% -$2.16M
ETV
4523
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.66B
$61K ﹤0.01%
3,822
-12,109
-76% -$199K
FLIC
4524
DELISTED
First of Long Island Corp
FLIC
$61K ﹤0.01%
2,971
+1,362
+85% +$28.6K
OSBC icon
4525
Old Second Bancorp
OSBC
$1.29B
$61K ﹤0.01%
4,695
+2,228
+90% +$26.7K

Similar funds

Citigroup's Q3 2021 Portfolio in Review

As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.

  • Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
  • Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
  • Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
  • Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
  • Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
  • Citigroup opened 423 new positions and closed 793 in Q3 2021.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.